CHELSEA BERNARD: Open Payments
NPI 1770175481 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 26 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $701 · 2025 $689
Food & beverage: $689
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $306 |
| GlaxoSmithKline, LLC. | 9 | $170 |
| Grifols USA, LLC | 2 | $50 |
| Philips North America LLC | 2 | $41 |
| JAZZ PHARMACEUTICALS INC. | 1 | $37 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $18 |
| GENZYME CORPORATION | 1 | $18 |
Products named: BREZTRI, NUCALA, TRELEGY ELLIPTA, AIRSUPRA, Prolastin-C Liquid, DUPIXENT, XYWAV, INSPIRE.
Industry payments across IL — which companies pay providers there.
